Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following ...

Expert Rev Vaccines. 2008;7(2):223-240. ME-TRAP Oxford University, MVI, Wellcome Trust Multiepitope string expressed in fowlpox and MVA Liver stage IIb CS + LSA1 epitope in attenuated viruses ...

GSK is doubling production of its AS01 adjuvant – used to boost the immune response to vaccines – for use in the malaria shot as it anticipates rising demand, and will work through its ...

pharmaphorum is pleased to interview here Dr Sophie Biernaux who serves as head of the Malaria Vaccine Franchise for GlaxoSmithKline Vaccines, where she leads the company's research and ...

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

While Moderna represents a concentrated bet on vaccines, Pfizer, GSK (GSK), and Sanofi (SNY)—leading vaccine makers in the U.S.—are huge, diversified companies selling an array of products.

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...